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esponsibility of Xi’Abstract In this work, the nickel–aluminum layered double hydroxide (Ni–Al LDH) with nitrate
interlayer anion was synthesized and used as a solid phase extraction sorbent for the selective separation
and pre-concentration of mefenamic acid prior to quantiﬁcation by UV detection at λmax¼286 nm.
Extraction procedure is based on the adsorption of mefenamate anions on the Ni–Al(NO3
) LDH and/or
their exchange with LDH interlayer NO3
 anions. The effects of several parameters such as cations and
interlayer anions type in LDH structure, pH, sample ﬂow rate, elution conditions, amount of nano-sorbent
and co-existing ions on the extraction were investigated and optimized. Under the optimum conditions,
the calibration graph was linear within the range of 2–1000 mg/L with a correlation coefﬁcient of 0.9995.
The limit of detection and relative standard deviation were 0.6 mg/L and 0.84% (30 mg/L, n¼6),
respectively. The presented method was successfully applied to determine of mefenamic acid in human
serum and pharmaceutical wastewater samples.
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Mefenamic acid (MFA, 2-(2,3-dimethyl phenyl) aminobenzoic acid)
is a prevailing non-steroidal anti-inﬂammatory drug which is used
as a potent analgesic and anti-inﬂammatory agent in the treatment of
several pathologies such as osteoarthritis, nonarticular rheuma-
tism, sport injuries, and other painful musculoskeletal illnessesier B.V. All rights reserved.
H. Abdolmohammad-Zadeh et al.332[1,2]. Overdose of mefenamic acid produces toxic metabolite
accumulation that causes nausea, vomiting and occasionally bloody
diarrhea [1]. On the other hand, MFA is a diphenylamine derivative
pollutant and the third compound on the European Union list of
priority pollutants [3]. Many studies have revealed that MFA cannot
be effectively removed by conventional sewage treatment plants and
that it has been detected at trace level in the efﬂuent of wastewater
treatment plants [4–7]. Due to the vital importance and widespread
use of MFA, the need for the development of simple and sensitive
analytical methods for trace analysis of drug is increasing.
So far, various analytical methods regarding MFA determination
in pharmaceutical formulations and biological ﬂuids have been
published in literature. Some reported methods are spectrophoto-
metry [8–11], ﬂuorimetry [12–14], potentiometry [15–18], chroma-
tography [19–23], chemiluminescence [24,25] and capillary
electromigration [26,27]. However, to determine the trace levels
of drug, spectrophotometry may be used, especially in combination
with extraction for separation of special purpose component from
the main admixture. Solid-phase extraction (SPE) techniques have
recently been among the most popular separation methods for the
enrichment of analytes prior to their determination. The basic
principle of SPE is the pre-concentration and puriﬁcation of analytes
from solution by sorption on a solid sorbent [28]. SPE has several
advantages over other techniques, such as low cost, low consump-
tion of organic solvents, high enrichment factor, high recovery,
safety with respect to hazardous samples and the ability of
combination with different detection techniques in the form of on-
line or off-line mode [29]. Recently, nano-meter sized materials
have been used as sorbents in SPE procedures.
Layered double hydroxides (LDHs) are a class of synthetic
ionic inorganic compounds with a similar structure to clays and




where M2þ is a divalent metal ion like Zn, Mg, Cu, Co or Ni,
M3þ is a trivalent metal ion like Al, Fe or Cr, x is the ratio of
M3þ/(M2þþM3þ) and An– is a n-valent anion [30]. The layer
structure of LDHs is based on that of brucite [Mg(OH)2], which is
typically associated with small polarizing cations and polarizable
anions. Their structure is based on a series of layers, where a
divalent metal cation is located in the center of octahedron, and
two-dimensional inﬁnite layers are formed by edge-sharing of
octahedral. The partial substitution of divalent cations by trivalent
ones generates a positives charge on the layers that is balanced byScheme 1 Ion exchange mechanism of mefenamate ananions or molecules of solvent. Interlayer anions can be exchanged
with various kinds of inorganic or organic anions by ion exchange
reaction or surface adsorption [31,32]. Scheme 1 shows ion
exchange mechanism of mefenamate anions, as organic anions,
with the interlayer anions in a LDH structure.
In the present work, a simple SPE system based on Ni–Al(NO3
–)
LDH was developed for the separation and pre-concentration of
MFA prior to determination by spectrophotometry. To the best of
knowledge, there is no report concerning the application of the
LDHs in SPE of MFA. The effect of various experimental
parameters on the extraction efﬁciency of MFA was investigated
and the presented method was successfully used for trace analysis
of MFA in various real samples.2. Experimental
2.1. Apparatus and instruments
The UV–vis absorption spectra and intensity measurements are
recorded on a 1601 PC UV–vis spectrophotometer (Shimadzu,
Japan). A 2 mL polypropylene cartridge (30 mm 7 mm i.d.)
(Shafa Co., Iran) containing 250 mg of Ni–Al(NO3
) LDH with
cotton-ﬁtted ends is used for the extraction of the analyte. A
vacuum pump model DV-85N-250 (Platinum Co., USA) is used
for controlling the ﬂow rate of solution throughout the column.
In order to obtain better insight into the structural properties of
LDH, XRD data were collected on a Brucker-D8 advance X-ray
powder diffractometer using CuKα radiation source (λ¼0.154 nm)
operating at 40 kV and 30 mA. The patterns were recorded at 2θ
from 21 to 701 at room temperature. Also, Fourier transform
infrared (FT-IR) spectra (4000–400 cm1) were recorded using a
Shimadzu FT-IR Spectrometer, model 8400 (Japan). The samples
were mixed with KBr with a sample/KBr weight ratio of 1/100 and
pressed into a disk. Morphological characterization of the synthe-
sized Ni–Al(NO3
) LDH was performed using a scanning electron
microscope (SEM) model Hitachi S 4160 and a transmission
electron microscope (TEM) model PHILIPS SM10. A centrifuge
(Shimifann CE. 86) with a relative centrifugal force of 2810g
(4000 rpm) was used to accelerate the phase separation. The pH
was adjusted using a Motrohm pH-meter (model 827, Switzerland)
with a precision of 70.01. An electrical furnace (Exciton Co.,ions with the interlayer anions in a LDH structure.
Extraction of mefenamic acid by Ni–Al layered double hydroxide 333Iran) with an accuracy of 71 1C was applied to control the
temperature in LDH synthesis process.
2.2. Standard solutions and reagents
All the chemicals were of analytical grade and all solutions were
prepared with high-purity deionized water (Shahid Ghazi Co.,
Tabriz, Iran). A 1000 mg/L stock solution of mefenamic acid was
prepared by dissolving appropriate amount of reagent in deionized
water. Working standard solutions were prepared daily by suitable
stepwise dilution of the stock solutions with deionized water and
shaking them just prior to use. All salts used for the interference
study, NaOH, NaCl, and LDH precursors, i.e., puriﬁed nickel
nitrate hexahydrate (Ni(NO3)2  6H2O, 99%) and aluminum nitrate
nonahydrate (Al(NO3)3  9H2O, 99%) were purchased from Merck
(Darmstadt, Germany). All the plastic and glassware was properly
aged in 15% (v/v) nitric acid at least overnight, and subsequently
washed three times with deionized water prior to use.
2.3. Preparation of nickel–aluminum layered double hydroxide
The Ni–Al(NO3
) LDH was prepared by the co-precipitation
method with controlled pH, and followed by hydrothermal
treatment according to our previous work [33] with some
modiﬁcations. 0.581 g Ni(NO3)2  6H2O and 0.375 g Al
(NO3)3  9H2O were dissolved in 30 mL deionized water under
vigorous stirring at room temperature. The pH of the reaction
mixture was adjusted to 9.6 by addition of 1 M NaOH solution.
The reaction continued for another 30 min under nitrogen protec-
tion. Then, the obtained slurry was subjected to hydrothermal
treatment at a constant temperature of 90 1C for about 24 h. The
obtained product was separated by centrifugation at 4000 rpm for
10 min, washed several times with deionized water and dried at
60 1C.
2.4. Column preparation
The column was prepared by introducing 250 mg of synthesized
nano-sorbent into a 2 mL polypropylene cartridge. The ends of the
column were plugged with a small portion of cotton wool to retain
the nano-sorbent in the column. Before loading the sample, 2.5 mL
of 1 M NaOH solution was passed through the column to clean it.
Then, the column was conditioned by passing 5 mL of deionized
water prior to each use.
2.5. Sample preparation
2.5.1. Wastewater
The wastewater samples were collected in pre-washed (with
detergent, deionized water, dilute HNO3 and deionized water,
respectively) polyethylene bottles from different efﬂuents of
Zahravi Pharmaceutical Manufactory (Tabriz, Iran). These samples
were ﬁltered through black band ﬁlter paper and centrifuged to
remove any suspended particulate. Then, aliquots of 200 mL from
samples were analyzed within 24 h of collection without previous
treatment.
2.5.2. Human serum
Human blood samples were obtained from healthy volunteers and
patients that consumed the mefenamic acid at Ali-Nasab hospital
(Tabriz, Iran). To prepare serum samples, they were drawn into thetest tube, centrifuged at 3000 rpm for 10 min and then allowed to
stand at 4 1C until the phase separation was done. The serum
samples were kept in a freezer (80 1C) until analysis. A 500 μL
of each serum sample was transferred into a 25 mL volumetric
ﬂask and diluted to the mark with deionized water. Finally, the
concentration of mefenamic acid in the obtained sample solution
was determined as described in Section 2.6.
2.6. General procedure
An aliquot of 200 mL from aqueous standard or sample solution
containing MFA (pH 7) in the range of 2–1000 mg/L was passed
through the Ni–Al(NO3
) LDH nano-sorbent in a column at a ﬂow
rate of 2 mL/min. After sample loading, 2.5 mL of 1 M NaOH
solution was used for the elution of the retained analyte from the
column. The concentration of mefenamic acid was subsequently
determined spectrophotometrically by measuring the absorbance
of the solution at λ¼286 nm.3. Results and discussion
3.1. Selection of layered double hydroxide
The charge density and anion exchange capacity of the LDHs were
controlled by varying the type of di- and trivalent cations and their
ratios in the LDH structure. The nature of the layer cations can be
changed among wide possible selection (almost restricted by size
and charge), and because of weak LDHs interlayer bonding, the
nature of interlayer anions can also be freely selected [34]. There-
fore, seven LDHs with different cations i.e., Zn2þ, Ni2þ, Mg2þ,
Al3þ and Fe3þ and same interlayer anion (nitrate) were synthesized
and used as nano-sorbents in SPE of MFA. The results are
displayed in Fig. 1A. As can be seen, the best recovery was
achieved in the case of Ni–Al LDH with 1:1 Ni2þ:Al3þ molar ratio.
The type of interlayer anion is important and can affect the retention
efﬁciency of analytes. Therefore, three Ni–Al LDHs with different
interlayer anions such as SO4
2–, NO3
– and CO3
2– were synthesized and
tested for SPE of MFA. As shown in Fig. 1B, the highest recovery
was obtained in the case of NO3
– interlayer anion. So, Ni–Al(NO3
)
LDH was used as a nano-sorbent in further SPE experiments.
3.2. Characterization of nano-sorbent
The powder X-ray diffraction (XRD) is a very powerful technique
for characterizing the structure of materials. Fig. 2A shows XRD
pattern of the Ni–Al(NO3
) LDH nano-sorbent. It can be seen that
the synthesized LDH has the characteristic structure of
hydrotalcite-like compounds. This fact was veriﬁed by the existing
characteristic reﬂection peaks of (003), (006), (009) planes and the
typical doublet of (110)–(113) planes in XRD pattern of LDH. The
Fourier transform infrared (FT-IR) spectrum which is used for
identifying the nature and symmetry of interlayer anions and the
presence of impurity phases was included in Fig. 2B. The broad
band around 3517 cm1 can be assigned to the stretching
vibration of the hydroxyl groups of LDH layers and interlayer
water molecules. Also, the weak band at 1766 cm1 is due to the
bending mode of interlayer water molecules and the band with
maximum peak at 1379 cm1 belongs to the stretching vibration
of NO3
 ions intercalated in the interlayer gallery. Finally, bands at
lower wavenumbers (400–800) are due to vibrational modes of
Fig. 1 Effect of (A) LDH type with the same interlayer anion, and (B) interlayer anion type between the hydroxide layers in Ni–Al LDH
nano-sorbent, on the retention of MFA.
Fig. 2 (A) XRD pattern, (B) FT–IR spectrum, (C) SEM image and (D) TEM image of Ni–Al(NO3
) LDH.
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scopy (SEM) was employed to explore the morphology of the nano-
sorbent. SEM image of Ni–Al(NO3
) LDH (Fig. 2C) shows an
aggregate due to the collection of crystallites as small pseudo-
hexagonal platelets after thermally treated at 90 1C for about 24 h.
The approximate sizes of the particles fall in the 10–60 nm range.
Transmission electron microscopy was also employed to explore the
morphology and distribution pattern of the nano-structured
Ni–Al(NO3
) LDH in a colloidal suspension. As can be seen from
Fig. 2D, the particles are all generally hexagonal plate-like in shape
forming a roughly mono-dispersed suspension.3.3. Optimization of solid phase extraction conditions
3.3.1. Effect of pH
The effect of pH was studied as the ﬁrst important factor for the
quantitative measurement of analyte. The retention of analyte by
nano-sorbent depends on the pH at which electrostatic interaction
between LDH layers and analyte was facilitated. The inﬂuence of
pH on the analyte recovery was tested over the pH range of
4.0–12.0. The resulting solutions’ pH(s) were adjusted with
minimal volume of diluted HNO3 and/or NaOH solutions. The
results illustrated in Fig. 3 show that the highest recovery could be
Fig. 3 Effect of sample pH on the retention of MFA on the
Ni–Al(NO3
) LDH nano-sorbent.
Fig. 4 Effect of the Ni–Al(NO3
) LDH amount on the retention of MFA.
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signiﬁcant fractions of mefenamate ion (pKa¼4.2) changed to
the corresponding protonated form which is not intercalated into
the LDH gallery by ion exchanging. Also, at pH above 9.0, an
increase in the concentration of the competing OH anions is
responsible for the observed decrease in the recovery. Therefore,
pH 7 was chosen as optimum value.3.3.2. Effect of the nano-sorbent amount
To test the effect of the nano-sorbent amount on the quantitative
extraction of MFA, the extraction was conducted by varying the
amounts of Ni–Al(NO3
) LDH from 50 to 500 mg. As shown in
Fig. 4, the recovery of MFA was not affected by the nano-sorbent
amount in the range between 200 and 500 mg. Consequently,
250 mg of the nano-sorbent was used in all further experiments.3.3.3. Optimization of elution conditions
In order to choose the best reagent for stripping of the retained
mefenamate ions on Ni–Al (NO3
) LDH, various eluents such as
NaOH, NaCl, NaF, NaBr and Na2CO3 were tested. Among these
reagents, NaOH solution provided the highest recovery (Fig. 5A).
The concentration of the NaOH solution was also investigated in
the range of 0.53.0 M. Based on the obtained results, 1 M NaOH
was sufﬁcient for complete elution of the retained analyte on the
nano-sorbent. The volume of eluent is important for obtaining the
high enrichment factor. So, the effect of elution volume on the
analyte recovery was studied in the range between 0.5 and 3.5 mL.
As shown in Fig. 5B, the minimum volume of NaOH required for
the quantitative elution was 2.5 mL. As a result, 2.5 mL of 1 M
NaOH was employed as an eluent in further experiments.
3.3.4. Effect of sample loading ﬂow rate
The sample ﬂow rate through the packed column is a very
important parameter, since the retention of analyte on the sorbent
depends on the ﬂow rate of sample solution. In fact, the sample
ﬂow rate not only affects the retention of analyte but also is one of
the variables that control the analysis time. The inﬂuence of the
sample loading rate on the recovery was investigated between 0.5
and 4.5 mL/min. Fig. 6 shows that the sample solution ﬂow rate in
the interval 0.52.5 mL/min had no signiﬁcant inﬂuence on the
recovery of MFA. However, at ﬂow rates higher than 2.5 mL/min
the recovery of the analyte reduced. Thus, all subsequent experi-
ments were performed at a sample ﬂow rate of 2.0 mL/min.
3.3.5. Sorption capacity
To determine the sorption capacity, 250 mg of the nano-sorbent
was added to 10.0 mL of solution containing 70 mg/L of MFA.
The mixture was then magnetically stirred for 60 min and the
supernatant was separated by a ﬁlter paper. Loaded MFA in the
LDH nano-particles was stripped with 2.5 mL of 1.0 M NaOH and
concentration of the analyte was then determined spectrophoto-
metrically after appropriate dilution. As a result, capacity of
Ni–Al(NO3
) LDH for MFA was found to be 30.0 mg/g.
3.3.6. Reusability of the nano-sorbent
The potential regeneration and stability of the nano-sorbent were
investigated. The column packed with 250 mg sorbent was rinsed
with 2.5 mL of 1.0 M NaOH and 5.0 mL deionized water, before
application in the next one. After at least 250 times of recycling,
there was no obvious decrease in the recovery of the analyte. In
fact, this is one of the advantages of the LDHs as solid phase
extraction sorbents.
3.4. Study of interferences
The inﬂuence of some potentially interfering ions on the determina-
tion of 60 mg/L MFA using the developed method was investigated.
The tolerable limit was deﬁned as the highest amount of interfering
ion that produced an error not exceeding75%. The obtained results
are given in Table 1. It can be seen that most of the examined ions
did not interfere with the extraction and determination of mefenamic
acid. Additionally, the inﬂuence of frequently encountered excipients
and additives on the determination of 60 mg/L MFA was studied by
adding different amounts of possible interferents to sample. No
interference was observed from the presence of lactose, glucose,
citrate, saccharose, starch, talk and stearate in the ratios commonly
used in pharmaceutical preparations.
Fig. 6 Effect of sample loading ﬂow rate on the retention of MFA on
the Ni–Al(NO3
) LDH nano-sorbent.
Table 1 Tolerance limits of interfering ions in the determi-
nation of 60 mg/L of mefenamic acid.
Coexisting ion Foreign ion to
analyte ratio
Naþ, Kþ, Ca2þ, Mg2þ, Fe2þ, Ni2þ, Cu2þ,








2 , Br 200:1
F, CO3
2 , Cl 50:1
Fig. 5 Effect of (A) type of eluent and (B) eluent volume on the elution of mefenamate ions from the Ni–Al(NO3
) LDH nano-sorbent.
Table 2 Optimum SPE conditions and analytical characteristics
of the presented method for MFA separation and determination.
Condition and parameter Value
SPE condition
pH 7.0
Amount of sorbent (mg) 250
Eluent volume (mL) 2.5
Eluent concentration (M) 1
Sample ﬂow rate (mL/min) 2
Maximum sample volume (mL) 200
Analytical parameter




Limit of detection (μg/L)a 0.6
RSD (%) (n¼6)b 0.84 (30)
Enrichment factorc 80
aCalculated as three times the standard deviation of the blank
signal divided by the calibration curve slope.
bValue in parentheses is the MFA concentration (mg/L) for which
the RSD was obtained.
cEnrichment factor calculated as the ratio between the volume of
the initial aqueous solution and the ﬁnal elution volume.
H. Abdolmohammad-Zadeh et al.3363.5. Method validation and analysis of real samples
In the optimum conditions, a calibration curve was plotted for MFA
by using a series of standard solutions. The linear concentration range
was between 2.0 and 1000.0 mg/L, with a correlation coefﬁcient of
0.9995. The regression equation was ΔA¼0.031Cþ0.011, where ΔA
is the blank-corrected absorbance intensity and C is the concentration
of MFA in mg/L, respectively. The limit of detection (LOD) and limit
of quantiﬁcation (LOQ), deﬁned as 3Sb/m, and 10Sb/m (where Sb is
the standard deviation of the blank and m is the slope of the
calibration curve) were 0.6 mg/L and 2.0 mg/L, respectively. The
relative standard deviation (RSD) resulting from the analysis of 6
replicates of 200 mL solution containing 30 mg/L of MFA was 0.84%.
The enrichment factor, deﬁned as the ratio between the volume of the
initial aqueous solution and the ﬁnal elution volume, was 80. The
optimum experimental conditions and analytical characteristics of the
presented method are summarized in Table 2.
To explore the reliability of the method, the presented method
has been successfully applied to determine MFA in pharmaceuticalwastewater and human serum samples. The results are given in
Table 3. The accuracy of the established procedure was veriﬁed by
the analysis of the samples spiked with different levels of the
Table 3 Determination of MFA in real samples (results of recoveries of spiked samples analysis).
Samples Added MFA (μg/L) Found MFA (μg/L) Recovery (%)
Wastewater samplesa
Sample 1  135.073.1 
125 262.072.0 101.6
Sample 2  135.073.1 
125 265.073.2 104.0
Sample 3  121.072.6 
125 247.074.5 100.8
Sample 4  160.072.6 
125 289.072.4 103.2
Serum samplesb
Sample 1  51.370.3 
50 103.070.3 103.4
100 154.071.0 102.7
Sample 2  45.370.6 
50 93.771.7 96.8
100 140.071.9 94.7
Control samplec   
50 48.671.1 97.2
100 99.072.1 99.0
aCollocated from different efﬂuents of Zahravi Pharmaceutical Manufactory, Tabriz, Iran.
bObtained from Ali-Nasab hospital, Tabriz, Iran.
cHealthy volunteer.
Table 4 Comparison of analytical characteristics of the presented method with other techniques for determination of mefenamic acid.
Method Linear range (mg/mL) LOD (mg/mL) RSD (%) Reference
Spectrophotometry 2–10 1.10 2.07 [8]
Spectroﬂuorometry 0.39–3.90 – 1.11 [12]
DPV 0.048–36.190 0.019 4.60 [18]
HPLC/UV 0.025–2.000 0.015 11.7 [19]
GC 1–25 – – [23]
CL 0.05–6.00 0.05 1.1 [25]
CZE 0.4–40.0 0.0003 o0.6 [27]
SPE–LC–MS 0.005–0.500 0.0016 1.3 [37]
SPE–Spectrophotometry 0.002–1.000 0.0006 0.84 This work
DPV: Differential pulse voltammetry, HPLC: high-performance liquid chromatography, GC: gas chromatography, CL: chemiluminescence detection,
CZE: capillary zone electrophoresis, SPE: solid phase extraction, LC–MS: liquid chromatography–mass spectrometry.
Extraction of mefenamic acid by Ni–Al layered double hydroxide 337known amount of MFA prior to preparation and analysis according
to the general procedure. The obtained relative recoveries between
94.7% and 104.0% conﬁrmed the accuracy of the presented
method. In addition, the presented method was successfully
applied to the analysis of MFA in its pharmaceutical dosage form
(250 mg per capsule). It was found that the MFA content measured
by the presented method (252.37 3.4) was in good agreement
with those obtained by the standard method [35] (250.872.6),
which involves the direct titration of MFA with NaOH in an
ethanolic medium. Statistical analysis [36] of the results using the
Student t-test showed no signiﬁcant difference at 95% conﬁdence
level between the performance of the two methods as regard to
accuracy and precision.3.6. Comparison with other methods
A comparison of analytical features of the presented method with
those of some previously reported methods for MFA determinationis shown in Table 4. The results indicate that LOD and RSD of the
developed method are better than or comparable with most of the
other methods. The presented method shows good accuracy and
repeatability for determination of MFA in pharmaceutical formu-
lation, pharmaceutical wastewater and serum samples.4. Conclusions
Layered double hydroxides can be regarded as a class of materials
that are simple to synthesize in the laboratory. In this study,
Ni–Al(NO3
–) LDH was employed as a nano-sorbent for the
separation and pre-concentration of MFA prior to determination
by spectrophotometry. It was found that Ni–Al(NO3
–) LDH showed
a good adsorption capacity for MFA, and the retained analyte can
be easily stripped with NaOH solution. This method is simple,
accurate with good recovery and low detection limit, repeatable
and matrix-independent at the low levels. The presented method,
which greatly improves the enrichment factor, can be applied for
H. Abdolmohammad-Zadeh et al.338the determination of MFA in various samples with complicated
matrices involving pharmaceutical wastewater and biological
samples. Moreover, the method represents a low cost, sensitive
and environment-friendly technique in the area of pharmaceutical
monitoring that can be recommended for the routine analysis of
MFA in quality control laboratories.
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